How might rheumatoid arthritis affect bone density?

Prepare for the ARRT Bone Densitometry Exam with our comprehensive quiz. Practice with multiple-choice questions designed to test your knowledge and skills. Get ready for success!

Multiple Choice

How might rheumatoid arthritis affect bone density?

Explanation:
Rheumatoid arthritis (RA) significantly impacts bone density, primarily due to the disease's inflammatory nature and the common treatment practices associated with it. The chronic inflammation that characterizes RA can directly influence bone metabolism. Inflammatory cytokines released during this condition can lead to increased bone resorption, decrease bone formation, and contribute to a higher risk of osteoporosis. Moreover, corticosteroids are often prescribed to manage inflammation and symptoms of RA. While these medications can be beneficial in treating the disease, one of their notable side effects is that they can lead to decreased bone density over time. This combination of inflammation from the disease itself and the effects of corticosteroids creates a situation where individuals with rheumatoid arthritis are at an increased risk for developing secondary osteoporosis. The other options do not align with the established understanding of how RA influences bone health. Notably, while some conditions may not impact bone density, RA is clearly linked to negative outcomes in this regard. Thus, understanding the connection between RA, inflammation, corticosteroid treatment, and bone density is crucial for effective management and patient care.

Rheumatoid arthritis (RA) significantly impacts bone density, primarily due to the disease's inflammatory nature and the common treatment practices associated with it. The chronic inflammation that characterizes RA can directly influence bone metabolism. Inflammatory cytokines released during this condition can lead to increased bone resorption, decrease bone formation, and contribute to a higher risk of osteoporosis.

Moreover, corticosteroids are often prescribed to manage inflammation and symptoms of RA. While these medications can be beneficial in treating the disease, one of their notable side effects is that they can lead to decreased bone density over time. This combination of inflammation from the disease itself and the effects of corticosteroids creates a situation where individuals with rheumatoid arthritis are at an increased risk for developing secondary osteoporosis.

The other options do not align with the established understanding of how RA influences bone health. Notably, while some conditions may not impact bone density, RA is clearly linked to negative outcomes in this regard. Thus, understanding the connection between RA, inflammation, corticosteroid treatment, and bone density is crucial for effective management and patient care.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy